Женское здоровье. Без стыда и глупостей
Часть 34 из 46 Информация о книге
Для доступа к библиотеке пройдите авторизацию
25. Lopez LM, Ramesh S, Chen M, et al. Progestin-only contraceptives: effects on weight. Cochrane Database Syst Rev 2016; (8): CD008815.
78
28. Lopez LM, Chen M, Mullins Long S, Curtis KM, Helmerhorst FM. Steroidal contraceptives and bone fractures in women: evidence from observational studies. Cochrane Database Syst Rev 2015; (7): CD009849.
79
29. Hidalgo M, Bahamondes L, Perrotti M, Diaz J, Dantas-Monteiro C, Petta C. Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years. Contraception 2002; 65(2): 129–32.
80
30. Lethaby A, Hussain M, Rishworth JR, Rees MC. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev 2015; (4): CD002126.
81
31. Darney PD, Stuart GS, Thomas MA, Cwiak C, Olariu A, Creinin MD. Amenorrhea rates and predictors during 1 year of levonorgestrel 52 mg intrauterine system use. Contraception 2018; 97(3): 210–4.
82
32. Gemzell-Danielsson K, Schellschmidt I, Apter D. A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena. Fertil Steril 2012; 97(3): 616–22 e1-3.
83
33. Crosby RA, DiClemente RJ, Wingood GM, Lang D, Harrington KF. Value of consistent condom use: a study of sexually transmitted disease prevention among African American adolescent females. Am J Public Health 2003; 93(6): 901–2.
84
34. Andrade AT, Pizarro Orchard E. Quantitative studies on menstrual blood loss in IUD users. Contraception 1987; 36(1): 129–44.
85
35. Hubacher D, Chen PL, Park S. Side effects from the copper IUD: do they decrease over time? Contraception 2009; 79(5): 356–62.
86
36. Duane M, Contreras A, Jensen ET, White A. The Performance of Fertility Awareness-based Method Apps Marketed to Avoid Pregnancy. J Am Board Fam Med 2016; 29(4): 508–11.
87
37. Berglund Scherwitzl E, Gemzell Danielsson K, Sellberg JA, Scherwitzl R. Fertility awareness-based mobile application for contraception. Eur J Contracept Reprod Health Care 2016; 21(3): 234–41.
88
19. National Health Service. Sexual and Reproductive Health Services – England 2016–17. https://digital.nhs.uk/catalogue/PUB30094.
89
38. Belker AM, Thomas AJ, Jr., Fuchs EF, Konnak JW, Sharlip ID. Results of 1,469 microsurgical vasectomy reversals by the Vasovasostomy Study Group. J Urol 1991; 145(3): 505–11.
90
39. Barnhart KT, Schreiber CA. Return to fertility following discontinuation of oral contraceptives. Fertil Steril 2009; 91(3): 659–63.
91
78
28. Lopez LM, Chen M, Mullins Long S, Curtis KM, Helmerhorst FM. Steroidal contraceptives and bone fractures in women: evidence from observational studies. Cochrane Database Syst Rev 2015; (7): CD009849.
79
29. Hidalgo M, Bahamondes L, Perrotti M, Diaz J, Dantas-Monteiro C, Petta C. Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years. Contraception 2002; 65(2): 129–32.
80
30. Lethaby A, Hussain M, Rishworth JR, Rees MC. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev 2015; (4): CD002126.
81
31. Darney PD, Stuart GS, Thomas MA, Cwiak C, Olariu A, Creinin MD. Amenorrhea rates and predictors during 1 year of levonorgestrel 52 mg intrauterine system use. Contraception 2018; 97(3): 210–4.
82
32. Gemzell-Danielsson K, Schellschmidt I, Apter D. A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena. Fertil Steril 2012; 97(3): 616–22 e1-3.
83
33. Crosby RA, DiClemente RJ, Wingood GM, Lang D, Harrington KF. Value of consistent condom use: a study of sexually transmitted disease prevention among African American adolescent females. Am J Public Health 2003; 93(6): 901–2.
84
34. Andrade AT, Pizarro Orchard E. Quantitative studies on menstrual blood loss in IUD users. Contraception 1987; 36(1): 129–44.
85
35. Hubacher D, Chen PL, Park S. Side effects from the copper IUD: do they decrease over time? Contraception 2009; 79(5): 356–62.
86
36. Duane M, Contreras A, Jensen ET, White A. The Performance of Fertility Awareness-based Method Apps Marketed to Avoid Pregnancy. J Am Board Fam Med 2016; 29(4): 508–11.
87
37. Berglund Scherwitzl E, Gemzell Danielsson K, Sellberg JA, Scherwitzl R. Fertility awareness-based mobile application for contraception. Eur J Contracept Reprod Health Care 2016; 21(3): 234–41.
88
19. National Health Service. Sexual and Reproductive Health Services – England 2016–17. https://digital.nhs.uk/catalogue/PUB30094.
89
38. Belker AM, Thomas AJ, Jr., Fuchs EF, Konnak JW, Sharlip ID. Results of 1,469 microsurgical vasectomy reversals by the Vasovasostomy Study Group. J Urol 1991; 145(3): 505–11.
90
39. Barnhart KT, Schreiber CA. Return to fertility following discontinuation of oral contraceptives. Fertil Steril 2009; 91(3): 659–63.
91